This company has been acquired
Vifor Pharma Dividend
Dividend criteria checks 3/6
Key information
1.1%
Dividend yield
88%
Payout ratio
Industry average yield | 2.4% |
Next dividend pay date | n/a |
Ex dividend date | n/a |
Dividend per share | n/a |
Earnings per share | US$2.26 |
Dividend yield forecast in 3Y | 1.1% |
Recent dividend updates
Recent updates
Stability and Growth of Payments
Fetching dividends data
Stable Dividend: GNHA.F's dividends per share have been stable in the past 10 years.
Growing Dividend: GNHA.F's dividend payments have increased over the past 10 years.
Dividend Yield vs Market
Vifor Pharma Dividend Yield vs Market |
---|
Segment | Dividend Yield |
---|---|
Company (GNHA.F) | 1.1% |
Market Bottom 25% (US) | 1.5% |
Market Top 25% (US) | 4.8% |
Industry Average (Pharmaceuticals) | 2.4% |
Analyst forecast in 3 Years (GNHA.F) | 1.1% |
Notable Dividend: GNHA.F's dividend (1.11%) isn’t notable compared to the bottom 25% of dividend payers in the US market (1.6%).
High Dividend: GNHA.F's dividend (1.11%) is low compared to the top 25% of dividend payers in the US market (4.56%).
Earnings Payout to Shareholders
Earnings Coverage: At its current payout ratio (88.5%), GNHA.F's payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Insufficient data to calculate cash payout ratio to determine if its dividend payments are covered by cash flows.